Helsana HealthInvest
Corporate VC firmWe invest in start-ups that improve patients’ access to healthcare. We invest in companies that can demonstrate traction with a scalable business model and are already active in or want to enter the Swiss market.
Fund volume: CHF 100 million (Evergreen)
Stage: Series A to B
Initial ticket size: CHF 1–5 million
Geography: Europe, with a focus on DACH, Benelux and the Nordics
Our connection to an insurer means that we may also invest in companies in the fields of fintech, insurtech or cybersecurity.
What’s out of scope? Everything that’s clearly too early, too late, too small or too big. We don’t invest in biotechnology, life sciences or pharma.
Stages
3. Early Revenue
4. Scaling
Target countries
Lead
Sometimes
Tickets
$1M to $5M
Location
Zürichstrasse 130, Dübendorf, 8600, CH,
Germany,